Summarized by Masters of Longevity from PR Newswire.
Preclinical peptides reduced body weight and food intake and extended drug exposure.

Key Takeaways
- Lipidated peptides showed extended half-life in rodent and dog models.
- Selective peptides produced significant weight-loss and reduced food intake.
- PL2001 was selected for clinical development with IND activities ongoing.



